SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-023910
Filing Date
2022-11-09
Accepted
2022-11-09 16:25:17
Documents
67
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q scph-20220930.htm   iXBRL 10-Q 2257641
2 EX-31.1 scph-ex31_1.htm EX-31.1 18302
3 EX-32.1 scph-ex32_1.htm EX-32.1 15120
  Complete submission text file 0000950170-22-023910.txt   8397501

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT scph-20220930_pre.xml EX-101.PRE 301831
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT scph-20220930_cal.xml EX-101.CAL 50398
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT scph-20220930_lab.xml EX-101.LAB 414702
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT scph-20220930.xsd EX-101.SCH 46774
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT scph-20220930_def.xml EX-101.DEF 146939
61 EXTRACTED XBRL INSTANCE DOCUMENT scph-20220930_htm.xml XML 1754251
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38293 | Film No.: 221373056
SIC: 2834 Pharmaceutical Preparations